Global UV Infection Control Devices Market By Type (Mobile, Stationary, Others), By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Emergency Department, Others), By Region, Forecast & Opportunities, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 3.26 Billion
CAGR (2026-2031)	12.02%
Fastest Growing Segment	Mobile
Largest Market	North America
Market Size (2031)	USD 6.44 Billion

Market Overview

The Global UV Infection Control Devices Market will grow from USD 3.26 Billion in 2025 to USD 6.44 Billion by 2031 at a 12.02% CAGR. Global UV Infection Control Devices utilize ultraviolet electromagnetic radiation, specifically within the UV-C spectrum, to disrupt the genetic material of pathogens, thereby sterilizing air, water, and surfaces in healthcare and industrial environments. The market is primarily supported by the escalating prevalence of hospital-acquired infections and the rigorous implementation of infection prevention protocols mandated by regulatory health authorities. Furthermore, the rising operational necessity for automated, non-contact disinfection methods to ensure consistent hygiene standards in high-traffic facilities significantly reinforces the demand for these systems.

One significant challenge that could impede market expansion is the inherent safety risk associated with direct UV-C exposure, which can cause damage to human skin and eyes, necessitating stringent safety protocols that may delay deployment. According to the World Health Organization, in 2024, new data indicated that up to 3.5 million patients could die annually from healthcare-associated infections without the urgent implementation of enhanced infection prevention measures. This critical data underscores the urgent requirement for effective sterilization technologies despite the operational complexities involved.

Key Market Drivers

Technological advancements in UV-C LED efficiency and lifespan are fundamentally reshaping the Global UV Infection Control Devices Market by enabling more compact, energy-efficient, and mercury-free disinfection solutions. Advancements in solid-state lighting are rapidly overcoming the output limitations of legacy systems, facilitating broader industrial deployment. According to Nichia Corporation, October 2025, in a press release regarding their new UV-C LED light source, the company achieved a doubled output density compared to conventional models, which allowed their partner MIURA to increase water sterilization equipment capacity from 10 to 25 cubic meters per hour. Such efficiency gains are accelerating adoption in high-volume sectors like water treatment. Underscoring the scale of this expanding infrastructure, Xylem Inc., February 2025, in their 2024 full-year financial results, reported that total revenue reached $8.6 billion, reflecting significant investment in advanced water technologies including UV disinfection.

The rising prevalence of healthcare-associated infections (HAIs) serves as the second primary catalyst, compelling facilities to implement rigorous, non-contact sterilization protocols. The operational necessity for automated UV systems capable of neutralizing multi-drug resistant organisms without chemical residues is becoming paramount. According to the International Sanitary Supply Association, October 2025, in the 'Global HAI Data 2025' report, World Health Organization statistics indicated that deaths linked to antimicrobial resistance now exceed 5 million annually worldwide. This escalating mortality burden drives the urgent demand for effective infection prevention technologies to supplement manual cleaning. Consequently, the integration of UV disinfection devices into standard hospital hygiene protocols is becoming a mandatory safeguard to mitigate patient risk and reduce the financial liability associated with infection outbreaks.

Download Free Sample Report

Key Market Challenges

The inherent safety risk associated with direct UV-C exposure acts as a significant constraint on the Global UV Infection Control Devices Market. Since UV-C radiation can cause severe damage to human skin and eyes, manufacturers are compelled to integrate complex safety mechanisms, such as motion sensors, containment shielding, and remote operation modules, into their systems. These mandatory engineering requirements increase production costs and extend development timelines, making advanced sterilization solutions less accessible for budget-conscious facilities. Additionally, the liability concerns regarding accidental exposure in high-traffic environments create hesitation among end-users, leading to slower adoption rates in occupied spaces where continuous disinfection is most needed.

The necessity to comply with rigorous occupational safety standards further restricts the operational flexibility of these devices. According to the American Conference of Governmental Industrial Hygienists (ACGIH), in 2024, the association maintained strict Threshold Limit Values (TLVs) for ultraviolet exposure, specifying a daily skin exposure limit of approximately 479 millijoules per square centimeter for emerging 222 nm UV-C wavelengths over an eight-hour shift. This stringent limitation forces facility managers to cap the intensity and duration of device operation, thereby reducing the efficiency of rapid disinfection cycles and dampening the overall market demand for high-output systems.

Key Market Trends

The Integration of Artificial Intelligence and Machine Learning in Autonomous UV Robots is revolutionizing the market by shifting disinfection protocols from static, timer-based cycles to dynamic, intelligence-driven operations. Unlike legacy systems that follow fixed paths, next-generation robots utilize deep learning algorithms to map environments in real-time, identifying shadowed areas and adapting navigation to ensure complete pathogen reduction. This capability addresses the critical failure point of manual positioning, ensuring high-touch surfaces are not missed due to human error or obstacle occlusion. According to Pohang University of Science and Technology, June 2025, in the 'Intelligent Autonomous Wiping and UV-C Disinfection Robot' press release, their newly developed AI-driven system successfully achieved nearly 100% surface coverage in simulated hospital trials by autonomously replanning routes to avoid dynamic obstacles, significantly outperforming conventional pre-programmed units.

Concurrently, the Miniaturization of Components enabling Portable and Handheld Sterilization Devices is expanding the market's reach beyond institutional settings into mobile and battery-operated applications. This trend is heavily reliant on breakthroughs in the wall-plug efficiency of UV-C LEDs, which allow for high-intensity output without the thermal and power constraints of mercury-vapor lamps. As components shrink and energy conversion improves, manufacturers are developing compact sterilizers capable of sustained operation on battery power, facilitating point-of-use disinfection for portable electronics and medical tools. According to Nichia Corporation, January 2025, in the 'Mass Production of Industry-Leading High Efficiency Deep UV LEDs' press release, the company’s new NCSU434D package achieved a record wall-plug efficiency of 7.4%, a critical milestone that extends the operational runtime of portable devices and supports the broader adoption of handheld sterilization technology.

Segmental Insights

The Mobile segment is projected to emerge as the fastest-growing category within the Global UV Infection Control Devices Market due to the increasing demand for automated and flexible disinfection solutions in healthcare facilities. Unlike stationary units, mobile devices can navigate complex environments to eliminate shadowed areas, ensuring comprehensive pathogen reduction on high-touch surfaces. This rapid adoption is driven by the urgent need to mitigate healthcare-associated infections, prompting hospitals to integrate these units into cleaning protocols that align with stringent hygiene guidelines established by institutions such as the Centers for Disease Control and Prevention.

Regional Insights

North America maintains a leading position in the Global UV Infection Control Devices Market due to its established healthcare infrastructure and the high prioritization of patient safety. This dominance is driven by strict guidelines regarding hospital-acquired infections, which necessitate the adoption of effective sterilization technologies in medical facilities. Furthermore, the U.S. Food and Drug Administration supports market stability by enforcing safety standards for radiation-emitting electronic products. The concentration of key manufacturers within the region also facilitates the rapid distribution and integration of these devices, ensuring consistent availability for hospitals and clinics.

Recent Developments

• In October 2024, ams-OSRAM unveiled the OSLON UV 3535, a new high-power UV-C LED designed to meet the growing demand for mercury-free disinfection solutions. The new emitter delivers an output of 115 milliwatts at a wavelength of 265 nanometers, which is optimized for maximum germicidal effectiveness against pathogens. The component features a compact footprint and improved wall-plug efficiency, making it suitable for integration into various water, air, and surface treatment applications. This launch supports the industry's shift towards sustainable, long-lasting solid-state lighting technologies for infection control applications.
• In June 2024, R-Zero announced a strategic sales partnership with SC Johnson Professional to expand the reach of its technology-driven biosafety solutions in the healthcare sector. The collaboration integrates R-Zero's UV-C mobile disinfection tower, known as Arc, into SC Johnson Professional's portfolio of hygiene and cleaning products. The Arc device is capable of inactivating 99.99% of common microorganisms in large spaces within minutes. This partnership aims to provide healthcare facilities with comprehensive solutions that improve operational efficiencies, staff productivity, and patient safety through intelligent, data-driven disinfection protocols.
• In March 2024, Ushio highlighted a significant research breakthrough validating the efficacy of its Care222 Far-UVC technology. A study published in the journal Nature demonstrated that the company's 222nm Far-UVC light reduced airborne infectious viruses by 99.8% in an occupied indoor location. This research provided the first direct evidence of the technology's ability to effectively inactivate airborne pathogens in real-world settings with human occupants, without causing harm. The findings mark a critical step towards the broader adoption of continuous UV disinfection in public health strategies to mitigate the spread of airborne diseases.
• In January 2024, Ultraviolet Devices, Inc. (UVDI) introduced advanced infection control solutions at the Arab Health exhibition in Dubai. The company launched the UVDI-GO UV LED Surface Sanitizer, a handheld device designed for the rapid disinfection of high-touch surfaces by healthcare professionals. Additionally, they debuted the next-generation UVDI-360 Room Sanitizer, which now features "UV Smart Connect" cloud communications technology. This enhancement allows for the automatic transfer of device usage and health data to a digital hub, enabling healthcare facilities to efficiently manage their disinfection programs and generate comprehensive compliance reports without the need for manual tracking.

Key Market Players

• Xylem Inc.
• Trojan Technologies
• Halma Group
• Atlantic Ultraviolet Corporation
• American Ultraviolet
• Advanced UV, Inc.
• Lumalier Corporation
• Hoenle AG
• Evoqua Water Technologies LLC
• Germitec GmbH

By Type	By End User	By Region
Mobile Stationary Others	Hospitals & Clinics Ambulatory Surgical Centers Emergency Department Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global UV Infection Control Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• UV Infection Control Devices Market, By Type:

• Mobile
• Stationary
• Others

• UV Infection Control Devices Market, By End User:

• Hospitals & Clinics
• Ambulatory Surgical Centers
• Emergency Department
• Others

• UV Infection Control Devices Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE